The PBYI Paradox: Analysts Bearish But Forecast 178.18% Gains
October 17, 2019 at 08:43 AM EDT
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Puma Biotechnology Inc (PBYI). The average 12-month price target for PBYI — averaging the work of 6 analysts — reveals an average price target of $18.83/share..
